S&P 500   0.54 (-1.29%)
DOW   0.54 (-1.29%)
QQQ   274.64 (+1.32%)
AAPL   455.61 (+3.49%)
MSFT   216.35 (+1.60%)
FB   265.28 (+6.49%)
GOOGL   1,504.95 (+1.75%)
AMZN   3,225.00 (+0.62%)
NVDA   453.42 (+0.43%)
CGC   17.52 (-8.80%)
BABA   265.68 (+0.29%)
TSLA   1,489.58 (+0.31%)
MU   48.70 (-4.60%)
GE   6.33 (-1.09%)
AMD   86.71 (+1.64%)
T   29.84 (-0.03%)
F   6.93 (-0.43%)
ACB   10.31 (-3.73%)
GILD   68.81 (-0.28%)
NFLX   509.08 (+1.39%)
DIS   130.82 (+2.52%)
BAC   25.47 (+0.32%)
BA   172.20 (-1.19%)
S&P 500   0.54 (-1.29%)
DOW   0.54 (-1.29%)
QQQ   274.64 (+1.32%)
AAPL   455.61 (+3.49%)
MSFT   216.35 (+1.60%)
FB   265.28 (+6.49%)
GOOGL   1,504.95 (+1.75%)
AMZN   3,225.00 (+0.62%)
NVDA   453.42 (+0.43%)
CGC   17.52 (-8.80%)
BABA   265.68 (+0.29%)
TSLA   1,489.58 (+0.31%)
MU   48.70 (-4.60%)
GE   6.33 (-1.09%)
AMD   86.71 (+1.64%)
T   29.84 (-0.03%)
F   6.93 (-0.43%)
ACB   10.31 (-3.73%)
GILD   68.81 (-0.28%)
NFLX   509.08 (+1.39%)
DIS   130.82 (+2.52%)
BAC   25.47 (+0.32%)
BA   172.20 (-1.19%)
S&P 500   0.54 (-1.29%)
DOW   0.54 (-1.29%)
QQQ   274.64 (+1.32%)
AAPL   455.61 (+3.49%)
MSFT   216.35 (+1.60%)
FB   265.28 (+6.49%)
GOOGL   1,504.95 (+1.75%)
AMZN   3,225.00 (+0.62%)
NVDA   453.42 (+0.43%)
CGC   17.52 (-8.80%)
BABA   265.68 (+0.29%)
TSLA   1,489.58 (+0.31%)
MU   48.70 (-4.60%)
GE   6.33 (-1.09%)
AMD   86.71 (+1.64%)
T   29.84 (-0.03%)
F   6.93 (-0.43%)
ACB   10.31 (-3.73%)
GILD   68.81 (-0.28%)
NFLX   509.08 (+1.39%)
DIS   130.82 (+2.52%)
BAC   25.47 (+0.32%)
BA   172.20 (-1.19%)
S&P 500   0.54 (-1.29%)
DOW   0.54 (-1.29%)
QQQ   274.64 (+1.32%)
AAPL   455.61 (+3.49%)
MSFT   216.35 (+1.60%)
FB   265.28 (+6.49%)
GOOGL   1,504.95 (+1.75%)
AMZN   3,225.00 (+0.62%)
NVDA   453.42 (+0.43%)
CGC   17.52 (-8.80%)
BABA   265.68 (+0.29%)
TSLA   1,489.58 (+0.31%)
MU   48.70 (-4.60%)
GE   6.33 (-1.09%)
AMD   86.71 (+1.64%)
T   29.84 (-0.03%)
F   6.93 (-0.43%)
ACB   10.31 (-3.73%)
GILD   68.81 (-0.28%)
NFLX   509.08 (+1.39%)
DIS   130.82 (+2.52%)
BAC   25.47 (+0.32%)
BA   172.20 (-1.19%)
Log in

NASDAQ:TTNPTitan Pharmaceuticals SEC Filings & 10K Form

$0.30
+0.00 (+0.27 %)
(As of 08/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.30
Now: $0.30
$0.31
50-Day Range
$0.28
MA: $0.31
$0.41
52-Week Range
$0.14
Now: $0.30
$0.85
Volume3.20 million shs
Average Volume13.78 million shs
Market Capitalization$28.76 million
P/E RatioN/A
Dividend YieldN/A
Beta0.89

SEC Filings

Titan Pharmaceuticals (NASDAQ:TTNP) SEC Filings

DateFilerForm TypeView
08/05/2020
5:10 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2020
5:08 AM
Titan Pharmaceuticals (Filer)
Form DEFA14A
07/16/2020
2:06 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2020
2:04 PM
Titan Pharmaceuticals (Filer)
Form DEFA14A
07/08/2020
3:37 PM
Titan Pharmaceuticals (Filer)
Form DEFA14A
06/25/2020
5:02 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2020
4:28 PM
Titan Pharmaceuticals (Filer)
Form DEF 14A
05/15/2020
7:46 AM
Titan Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2020
3:48 PM
Titan Pharmaceuticals (Filer)
Form PRE 14A
03/16/2020
3:56 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2020
11:57 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2020
11:11 AM
Titan Pharmaceuticals (Filer)
Form DEFA14A
02/12/2020
5:00 AM
Titan Pharmaceuticals (Filer)
Form DEFA14A
01/31/2020
3:36 PM
Titan Pharmaceuticals (Filer)
Form DEFA14A
01/31/2020
3:31 PM
Titan Pharmaceuticals (Filer)
Form DEF 14A
01/27/2020
10:33 AM
Empery Asset Management, LP (Filed by)
Titan Pharmaceuticals (Subject)
Form SC 13G/A
01/22/2020
8:11 AM
Titan Pharmaceuticals (Filer)
Form PRE 14A
01/16/2020
4:21 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
2:14 PM
SABBY MANAGEMENT, LLC (Filed by)
Titan Pharmaceuticals (Subject)
Form SC 13G/A
01/09/2020
3:23 PM
Titan Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
01/07/2020
4:31 PM
Titan Pharmaceuticals (Filer)
Form 424B5
01/07/2020
4:18 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2020
3:27 PM
Titan Pharmaceuticals (Filer)
Form 424B5
12/31/2019
5:01 AM
Titan Pharmaceuticals (Filer)
Form DEFA14A
12/23/2019
12:37 PM
Titan Pharmaceuticals (Filer)
Form DEFA14A
12/20/2019
4:14 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
1:30 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2019
5:01 AM
Titan Pharmaceuticals (Filer)
Form DEF 14A
11/01/2019
6:35 PM
Titan Pharmaceuticals (Filer)
Form PRE 14A
10/22/2019
8:55 AM
Empery Asset Management, LP (Filed by)
Titan Pharmaceuticals (Subject)
Form SC 13G
10/18/2019
3:32 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2019
12:18 PM
Titan Pharmaceuticals (Filer)
Form 424B5
10/16/2019
11:15 PM
Titan Pharmaceuticals (Filer)
Form EFFECT
10/11/2019
12:44 PM
Titan Pharmaceuticals (Filer)
Form S-1/A
10/08/2019
4:28 PM
Titan Pharmaceuticals (Filer)
Form S-1/A
09/28/2019
2:04 AM
Titan Pharmaceuticals (Filer)
Form S-1/A
09/20/2019
10:30 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2019
8:44 AM
Titan Pharmaceuticals (Filer)
Form CT ORDER
09/18/2019
4:29 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2019
8:28 AM
Titan Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/23/2019
10:35 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
4:27 PM
Titan Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
08/08/2019
4:28 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
4:26 PM
Titan Pharmaceuticals (Filer)
Form 424B5
08/08/2019
3:56 PM
Titan Pharmaceuticals (Filer)
Form 424B5
08/07/2019
11:45 AM
SABBY MANAGEMENT, LLC (Filed by)
Titan Pharmaceuticals (Subject)
Form SC 13G
06/27/2019
3:12 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2019
3:20 PM
Hallberg Dane (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
3:06 PM
Titan Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2019
8:52 PM
Titan Pharmaceuticals (Filer)
Form 424B5
04/25/2019
8:49 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2019
11:15 PM
Titan Pharmaceuticals (Filer)
Form EFFECT
04/05/2019
3:35 PM
Titan Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/03/2019
3:30 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2019
3:30 PM
Rubin Marc (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
3:30 PM
BHONSLE SUNIL (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
5:05 AM
Titan Pharmaceuticals (Filer)
Form 10-K/A
04/01/2019
3:37 PM
Titan Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2019
4:36 PM
Beebe Katherine (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/25/2019
4:35 PM
Hallberg Dane (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/25/2019
1:29 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
5:10 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2018
6:50 PM
Titan Pharmaceuticals (Filer)
Form DEF 14A
12/06/2018
5:03 AM
Titan Pharmaceuticals (Filer)
Form PRE 14A
11/14/2018
3:03 PM
Titan Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/22/2018
4:27 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2018
3:38 PM
Recli Federico Seghi (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
3:51 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2018
4:45 PM
Recli Federico Seghi (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
6:09 PM
MACFARLANE M DAVID (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
6:06 PM
BHONSLE SUNIL (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
6:04 PM
MCNAB JAMES R (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
6:02 PM
Rubin Marc (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
6:00 PM
Akers Joseph A (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
4:13 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2018
5:06 AM
Titan Pharmaceuticals (Filer)
Form 424B3
09/20/2018
11:15 PM
Titan Pharmaceuticals (Filer)
Form EFFECT
09/20/2018
8:25 AM
Titan Pharmaceuticals (Filer)
Form S-1/A
09/20/2018
5:06 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2018
7:11 AM
Titan Pharmaceuticals (Filer)
Form S-1/A
09/10/2018
8:17 AM
Titan Pharmaceuticals (Subject)
Form FWP
09/10/2018
8:14 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2018
7:01 AM
Titan Pharmaceuticals (Subject)
Form FWP
09/04/2018
7:00 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2018
4:25 PM
Titan Pharmaceuticals (Filer)
Form S-1/A
08/17/2018
2:45 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2018
4:30 PM
Titan Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/08/2018
2:07 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2018
1:53 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2018
2:01 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2018
3:15 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2018
3:54 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2018
2:43 PM
Recli Federico Seghi (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/16/2018
3:15 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2018
3:02 PM
Titan Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/13/2018
7:01 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2018
12:32 PM
Titan Pharmaceuticals (Filer)
Form CT ORDER
04/02/2018
10:01 AM
Titan Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2018
2:56 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2018
3:37 PM
BHONSLE SUNIL (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 8/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.